Latest News and Press Releases
Want to stay updated on the latest news?
-
Dublin, Aug. 20, 2024 (GLOBE NEWSWIRE) -- The "Monkeypox Treatment Market: Focus on Therapeutics, Vaccines and Diagnostic Kits: Distribution by Type of Product, Drug Developers, Drug Candidates,...
-
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "MTG201 + nivolumab Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This report provides...
-
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "ADME Toxicology Testing Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global ADME toxicology testing...
-
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Global Biosimulation Market" report has been added to ResearchAndMarkets.com's offering. The advent of cutting-edge biosimulation technologies is...
-
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "OCS-01 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The landscape of acute ocular...
-
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Drug Discovery Informatics Market Size, Share & Trends Analysis Report by Workflow (Discovery Informatics, Biocontent Management), Services...
-
Dublin, Dec. 07, 2023 (GLOBE NEWSWIRE) -- The "Pozelimab Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
-
本提携では、サリプロ・バイオテックの独自の専門知識とSalipro®プラットフォーム技術を活用して困難な薬物標的を安定化し、住友ファーマの創薬プログラムによる化合物の薬理学的特性を研究 する。 スウェーデン・ストックホルム発, Sept. 12, 2023 (GLOBE NEWSWIRE) -- スウェーデンのバイオテクノロジー企業であるサリプロ・バイオテックAB (Salipro...
-
Die Zusammenarbeit nutzt die einzigartige Expertise von Salipro Biotech und die Salipro®-Plattformtechnologie zur Stabilisierung eines anspruchsvollen Wirkstoffziels, um die pharmakologischen...
-
La collaboration mobilise l'expertise unique de Salipro Biotech et sa plateforme technologique Salipro® pour stabiliser une cible pharmacologique difficile. Objectif : étudier les caractéristiques...